My name is Dr. SaraBañón Escandell, and I am the co-founder of IBIONS, an innovative SME dedicated to improving the health and quality of life of people with cancer through personalized, science-based nutritional changes. At IBIONS, we combine cutting-edge research in nutrition, metabolism, and autophagy with innovative technologies to design tailored nutritional plans that meet the specific needs of patients.
Our multidisciplinary team has extensive experience in the fields of clinical nutrition, cancer biology, and the development of technological tools to personalize nutritional interventions. We are committed to implementing solutions that integrate science and technology to positively impact people's lives.
We would be delighted to contribute to the consortium by offering our expertise in developing personalized nutrition strategies, our capacity for applied research, and our entrepreneurial perspective to translate research findings into practical and accessible solutions.
Thank you for your attention,
Dr. Sara Bañón Escandell
CEO, Co-founder of IBIONS and Medical Director.
IBIONS is an innovative SME dedicated to improving the health and quality of life of individuals, particularly cancer patients, through personalized, science-based nutritional interventions. Founded in 2021, IBIONS operates at the intersection of cutting-edge research, technological innovation, and practical healthcare solutions, making it a pioneer in the application of personalized nutrition as a therapeutic tool.
At IBIONS, we combine advanced expertise in nutrition science, metabolism, and autophagy with the latest technological approaches to design personalized nutritional strategies tailored to the specific needs of patients. Our mission is to use nutrition as a key modulator of health, targeting chronic metabolic diseases such as cancer.
Our multidisciplinary team includes experts in clinical nutrition, cancer biology, metabolic research, and data-driven health solutions. This diversity enables us to deliver high-quality, scientifically validated nutritional tools and interventions. Additionally, IBIONS is committed to bridging the gap between research and application, ensuring that the latest scientific advancements in nutrition and metabolism are translated into accessible and practical solutions for individuals worldwide.
Through collaborations with academic institutions, healthcare providers, and industry stakeholders, IBIONS actively contributes to fostering innovation in personalized nutrition and chronic disease prevention. We are uniquely positioned to contribute to the Future Foods initiative by providing expertise in personalized nutrition strategies, clinical validation, and the integration of research into real-world applications.
IBIONS is passionate about harnessing the potential of nutrition to promote better health outcomes and is eager to collaborate with international partners in this groundbreaking project.
For more information, please visit: www.ibions.com